Steven Lloyd Mayer

Dr. Mayer has more than 30 years of diversified experience in diagnostics, medical devices, and drug development. Since 2002, he has been a Scientific Consultant, Board member or an Advisor to several healthcare companies including: Abbott Labs, Pure Transplant Solutions, Pure MHC, GlucoSentient Inc., Rules Based Medicine, IAPAC, Mead West Vaco, Organ Recovery Systems and HBM BioVentures. From 1982 to 2002.

Dr. Mayer held roles of increasing responsibility at Abbott Laboratories where he began as a research engineer in Corporate Engineering; then as a Program Manager, Senior Strategic Planner, and Director of Health Economics in the Diagnostics Division; and lastly as a Medical Director of Pharmaco Economics and Outcomes Research and Associate Medical Director in Abbott’s Pharmaceutical Products Division. Dr. Mayer has a Doctor of Medicine and B.S. Chemical Engineering degrees, both from the University of Wisconsin-Madison.